Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RLYB is expected to report earnings to fall 9.52% to -18 cents per share on November 06
Q3'25
Est.
$-0.19
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.55
Q3'24
Beat
by $0.09
Q2'24
Missed
by $0.30
The last earnings report on May 08 showed earnings per share of -20 cents, beating the estimate of -28 cents. With 305.29K shares outstanding, the current market capitalization sits at 21.26M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLYB showed earnings on May 08, 2025. You can read more about the earnings report here.